Lake Street Maintains Buy on AEON Biopharma, Raises Price Target to $2

Benzinga · 1d ago
Lake Street analyst Thomas Flaten maintains AEON Biopharma (AMEX:AEON) with a Buy and raises the price target from $1 to $2.